baber/WOPTO huggingface dataset:
Patent CA-2601429-A1 (CA)
Inventor: SCHOTTEN HANS DIETER
IPC: H04B1/707
Filed: 2006-03-17
Abstract: L'invention concerne des techniques permettant de transmettre des données pourvues d'un brouillage spatio-temporel dans des systèmes cellulaires (par exemple, des systèmes à accès multiple par répartition de code). Au moins un flux de symboles de données est généré, mappé à une ou plusieurs voies physiques et étalé à l'aide de codes de canalisation pour les voies physiques. Le brouillage spatio-temporel est accompli sur au moins un flux de symboles de données afin de générer au moins deux flux de puces de sortie. Pour réaliser ce brouillage spatio-temporel, on peut procéder à une multiplication de matrices avec une séquence de matrices. Pour chaque intervalle de temps dans lequel le brouillage spatio-temporel est accompli, une matrice peut être choisie (par exemple, sur la base d'un code de brouillage pour une station de base) et des données devant être envoyées dans l'intervalle de temps sont multipliées par la matrice choisie. Les matrices utilisées pour le brouillage spatio-temporel peuvent être définies et choisies de différentes façons. Les flux de puces de sortie sont traités et transmis depuis les antennes de transmission respectives.
Patent CA-2604494-A1 (CA)
Title: Improved method and apparatus for treating bacterial infections in devices
Inventor: BALABAN NAOMI
IPC: C12M1/00
Filed: 2006-04-04
Abstract: An apparatus and method for treating or preventing bacterial colonization of medical devices, or the host itself, comprise combining an RNAIII inhibiting peptide (RIP) with the medical device, optionally with an antibiotic. Further, RIP may be used in a lock technique, comprising adding sufficient solution comprising RIP to occupy a space within the device, which provides a high concentration of RIP at the actual or potential site of infection and prevents the space from filing with blood. The invention thus allows a clinician to maximize the amount of RIP and an antibiotic used to clean the medical device, while, at the same time, retaining the device within the host.
Patent CA-2604625-A1 (CA)
Inventor: MICHELAKIS EVANGELOS
IPC: C12Q1/00
Filed: 2006-04-11
Abstract: The invention relates to the use of dichloroacetate and chemical equivalents thereof for the treatment of cancer by inducing apoptosis or reversing apoptosis-resistance in a cell Preferably, the dosage is 10-100 mg/kg Preferably, sodium dichloroacetate is used. The dichloroacetate may optionally be given in combination with a pro-apoptotic agent and/or a chemotherapeutic agent Preferably, the cancers treated are non-small cell lung cancer, glioblastoma and breast carcinoma.
Patent CA-2605793-A1 (CA)
Inventor: HEGLER RALPH PETER
IPC: B29C48/09
Filed: 2007-10-04
Abstract: An apparatus for the manufacture of compound pipes with an oval cross--section is equipped with mould halves which advance in a direction of pro-duction and of which two at a time combine as a pair on a moulding path to form one mould. An injection head of at least one extruder is arranged up--stream of the moulding path. An external nozzle used for the creation of an external tube is substantially circular in shape and is located at a distance upstream of the moulding path. An internal nozzle with a cross-section similar to the oval cross-section of the pipe to be created is located inside the moulding path. When entering the moulding path, the external tube ex-truded through the external nozzle is expanded in one direction and pressed together in a direction which is perpendicular to the former.
Patent CA-2606311-A1 (CA)
Inventor: HANSEN JUERGEN
IPC: A47G1/10
Filed: 2005-09-01
Abstract: The fabric frame system is disclosed to use a minimum number of component parts in order to assemble many types of display systems. The parts are sized with very tight tolerances to form support for specially produced fabric panels.
Patent CA-2606871-A1 (CA)
Title: Use of native peptides and their optimized derivatives for vaccination
Inventor: KOSMATOPOULOS KOSTANTINOS KOST
IPC: A61K38/08
Filed: 2006-05-09
Abstract: The present invention pertains to the field of vaccination, and more particularly to the fields of antitumor and antiviral vaccination. The invention relates to the use of a native peptide in a medicinal composition, for selecting and/or boosting part of a CTL immune response which has been initiated by an optimized immunogenic peptide derived from said native peptide. The invention also concerns vaccination kits which comprise several doses of optimized peptides and of their cognate native peptides.
Patent CA-2608596-A1 (CA)
Title: Method and system for making a payment through a mobile communication device
Inventor: ADISESHANN AJAY
IPC: G06Q20/00
Filed: 2006-10-27
Abstract: A method for making a payment through a mobile communication device, the method comprising: a. receiving transaction details of the payment by a Paymate, the transaction details being received from a payee, the transaction details comprising at least one of a transaction identifier and a transaction amount; b. sending a text message to the Paymate, the text message being sent by a payer, the text message comprising at least one of the transaction identifier, the transaction amount and a Personal Identification Number (PIN) of the payer; c. verifying the text message on the Paymate, the text message being verified with the transaction details received by the Paymate; d.  authenticating the payer on the Paymate, the authentication of the payer being based on at least one of an identification number of the mobile communication device, the PIN of the payer and the transaction amount, wherein the identification number of the mobile communication device is sent along with the text message; and e. sending a debit request to a debit server for debiting the transaction amount from an account of the payer, the account being located at the debit server, the debit server receiving the debit request from the Paymate.
Patent CA-2608700-A1 (CA)
Title: Providing traffic information relating to a prediction of speed on a link and using the same
Inventor: KIM YOUNG IN
IPC: G08G1/0969
Filed: 2006-05-17
Abstract: A method for processing traffic data is provided. The method includes receiving the traffic data (21,22,23) including a first identifier, information corresponding to a prediction of travel speed for a particular link, information corresponding to a location associated with the particular link, and information corresponding to a message management structure (21) including information corresponding to a version number of information reflected in the traffic data, the first identifier being an identifier revealing that the traffic data relates to a prediction of travel speed for the particular link. The method further includes decoding the traffic data.
Patent CA-2613221-A1 (CA)
Inventor: REYNOLDS JEFFREY S
IPC: A61K31/00
Filed: 2006-06-29
Abstract: Topical compositions and methods of using same for treating various skin disorders or conditions. In a particular aspect, these compositions comprise a storage- stable mixture of a benzoyl peroxide-containing composition, an antibiotic or a pharmaceutically acceptable salt or ester thereof, and a retinoid or a pharmaceutically acceptable salt thereof. In an alternative embodiment, these compositions comprise a storage-stable mixture of a retinoid or a pharmaceutically acceptable salt thereof and either a benzoyl peroxide-containing composition or an antibiotic or a pharmaceutically acceptable salt or ester thereof.
Patent CA-2614573-A1 (CA)
Inventor: OKUMURA YUKIHIRO
IPC: H04L1/22
Filed: 1996-02-23
Abstract: A variable rate transmission method that can vary the transmission rate of data. A transmitting side supplies a transmitted data sequence to an error detecting encoder 105 and a frame memory 103.  The frame memory 103 stores data of a variable length to be transmitted in one frame. The error detecting encoder 105 calculates an error detecting code (such as CRC code) for each frame of the transmitted data. A multiplexer 104 adds the calculated error detecting code ahead of the transmitted data to place it at the initial position of the frame, and sequentially outputs the data sequence frame by frame. A receiving side calculates an error detecting code of the data in each transmitted frame in the same manner as the transmitting side, and compares the calculated error detecting code with the error detecting code at the initial position of the frame. The end bit of the frame data is decided as a position at which the two error detecting codes coincide. This makes it possible to transmit variable length data without informing the receiving side of the data length in each frame. This is equivalent that the transmission rate can be varied freely.
Patent CA-2615757-A1 (CA)
Title: Reinforced open-hole zonal isolation packer
Inventor: O'MALLEY EDWARD J
IPC: E21B33/128
Filed: 2006-07-14
Abstract: A packer device and methods of use for a packer within uncased wellbore to form a complete fluid seal. The packer device (36) includes a central mandrel body (44) that retains a plurality of nested, telescopic expanding elements (50) that are moveable outwardly from the mandrel body. The mandrel body and expanding elements are surrounded by a load- distributing structure (58) as well as a sealing element (60), which is typically comprised of elastomer. The packer device is hydraulically actuated to urge the expansion members radially outwardly against the load-distributing structure and the sealing element.  Because there are a number of discrete expansion elements, the packer device is better able to create a fluid seal within an uncased borehole with surface irregularities.
Patent CA-2617665-A1 (CA)
Inventor: SETCHELL KENNETH DAVID REGINAL
IPC: C07D311/02
Filed: 2006-08-01
Abstract: A method for preparing an enantiomeric chromane, by asymmetrically hydrogenating a chromene compound in the presence of an Ir catalyst having a chiral ligand. The method includes the enantioselective preparation of enantiomeric equol. A preferred Ir catalyst has a chiral phosphineoxazoline ligand. Enantiomeric chromanes of high stereoselective purity can be obtained.
Patent CA-2621985-A1 (CA)
Title: Sigma ligands for neuronal regeneration and functional recovery
Inventor: URFER ROMAN
IPC: A61K31/485
Filed: 2006-10-31
Abstract: The invention discloses methods and compositions useful for facilitating neuronal regeneration and functional recovery in neurodegenerative diseases.  The methods and compositions utilize ligands for the sigma receptor, wherein the ligand is preferably AGY-94806, or salts, or solvates thereof. These molecules can be delivered alone or in combination with agents which treat or prevent neurodegenerative diseases such as those caused by ischemic stroke, diabetic peripheral neuropathy, cancer therapy induced neuropathy, multiple sclerosis, amyotrophic lateral sclerosis, traumatic brain injury, Huntington's disease, or Parkinson's disease. In other methods, the sigma receptor ligands are administered after stroke to facilitate functional recovery. The administration of the sigma receptor ligands effects faster functional recovery.
Patent CA-2623377-A1 (CA)
Inventor: NORIN JOHN L
IPC: H04L27/26
Filed: 2006-09-26
Abstract: Systems and methods for communication are disclosed. A system in accordance with the present invention comprises a communications system, comprising at least one transmitter station and at least one receiver station, the transmitter station and receiver station communicating using an Orthogonal Frequency Division Multiplexing (OFDM) schema, wherein OFDM signals are transmitted in a notched frequency band arrangement such that at least one other transmission within a notch of the notched frequency band is used outside of the communications system.
Patent CA-2627962-A1 (CA)
Inventor: DICKINSON THEODORE ELLIOT
IPC: B01D53/14
Filed: 2006-11-07
Abstract: A new functional fluid for the removal of contaminates such as but not limited to, acid causing components in gas, sulphur components and carbon oxides from fluid streams, and removal and treatment of NOX & SOX from post combustion emissions. Also described is the manufacturing process to produce the functional fluid both in a batch atmospheric process system as well as a closed system capable of operating at above or below atmospheric conditions.
Patent CA-2629412-A1 (CA)
Inventor: BARRY ALAN F
IPC: A01B73/02
Filed: 2008-04-17
Abstract: An agricultural implement, such as a planter, having a telescoping tongue for placing the implement in either a transport or field use configuration, includes an hydraulic pump located on the planter frame, preferably toward the rear, for powering the planting functions. A  mechanical drive line from the PTO of the tractor to the remote hydraulic pump is disengaged as the planter frame begins to move from the planting position. The drive line permits the tractor to make full 90° turns in the field.
Patent CA-2631100-A1 (CA)
Title: Fibrous dressing
Inventor: FLOYD HELEN
IPC: D04H1/728
Filed: 2006-11-27
Abstract: An apparatus for aspirating and/or cleansing wounds comprising a flow path comprising a wound dressing having a backing layer and at least one outlet pipe for connection to a fluid off take tube and which has a wound contact integer which in use is in contact with the wound bed and in which the wound contact integer comprises a biodegradable and/or bioabsorbable fibrous electrospun scaffold.
Patent CA-2634630-A1 (CA)
Inventor: RHYS-WILLIAMS WILLIAM
IPC: A61P31/00
Filed: 2006-12-22
Abstract: There is provided a process for the preparation of 5,15-bis-[4-(3- trrmethylarn-monio -propyloxy)-phenyl]-porphyrin dihalide, wherein the process comprises step (a) of providing 4-(3-bromopropyloxy)benzaldehyde, step (b) of providing dipyrrolmethane, step (c) of reacting the 4-(3-bromopropyloxy)-benzaldehyde with the dipyrrol-methane, together with trifluoro acetic acid, in the presence of an oxidation reagent to produce 5,15-bis-[4-(3-bromo- propyloxy)-phenyl]  -porphyrin which is purified by Soxhlet extraction from the adsorbed state on a bed of alumina under highly controlled conditions; and step (d) of reacting the 5,15-bis-[4-(3-bromo-propyloxy)-phenyl]-por-phyrin with trimethylamine in the presence of dry dimethylformamide to produce 5,15-bis-[4-(3 -trrmethylarnmonio-propyl-oxy)-phenyl]  -porphyrin dibromide. In a preferred embodi-ment, the process further comprises step (e) of passing the 5, 15-bis-[4-(3 -lrimemylammo-nio -propyloxy)-phenyl]-porphyrin di-bromide produced in step (d) through an anion exchanger to produce 5,15-bis-[4-(3- trimethylammo-nio -propyloxy)-phenyl]-porphyrin dichloride.  There is provided a process for the preparation of 5,15-bis-(4-{3-[(3-dimemylamino-propyl)-dimethyl-ammonio]-propyloxy} -phenyl]  -porphyrin dihalide.
Patent CA-2635231-A1 (CA)
Title: Protein kinase inhibitors
Inventor: WANG GARY
IPC: A61K31/519
Filed: 2006-12-28
Abstract: Compounds of formula (I) that inhibit protein kinases, compositions containing the compounds and methods of treating diseases using the compounds are disclosed.
Patent CA-2635332-A1 (CA)
Title: Method for detecting an available/unavailable state of packet transport network
Inventor: WANG YAN
IPC: H04L12/26
Filed: 2006-07-20
Abstract: A method for detecting an available/unavailable state of a packet transmission network includes the steps of: in the packet transmission network, detecting the severely errored second (SES) through the performance parameters of the packet transmission network, and detecting the available/unavailable time in the packet transmission network by reference to the SES. So the method of the packet transmission network entering or exiting the available/ unavailable state is realized, and the detection in the available time of the packet transmission network is realized. When the packet transmission network is available, the performance parameters of the packet transmission network is ensured to measure, and when the packet transmission network is unavailable, the measurement in the performance parameters of the packet transmission network is stopped. The method improves the packet transmission OAM mechanism, eliminates the defaults in the performance management of the packet transmission network.
Patent CA-2635632-A1 (CA)
Title: Turbomachine a double soufflante
Inventor: LE HONG SON
IPC: F02C7/36
Filed: 2008-06-26
Abstract: Turbomachine à deux soufflantes contrarotatives amont et aval entraînées par deux arbres coaxiaux contrarotatifs (20, 71) qui relient chacun une roue de soufflante (10, 12) à au moins une roue de turbine basse pression située à l'aval, la roue (12) de la soufflante aval étant reliée par sa partie aval à    son arbre d'entraînement (71).
Patent CA-2637010-A1 (CA)
Title: Multi-component pipette tip and associated methods
Inventor: STEED FREDRICK C
IPC: B01L3/02
Filed: 2007-09-28
Abstract: Described are pipette tips and methods of making the same. The pipette tips may include at least two components, an annular component and a tubular body component. The annular component may comprise a different and relatively more compliant material. The annular component may be partially or entirely telescopically received within the tubular body component. Alternatively, the annular component may comprise a proximal end of the pipette tip and the tubular body component may comprise a distal end of the pipette tip. A portion of the tubular body component may be telescopically received by the annular component or otherwise attached thereto. The pipette tip may be formed by first molding the annular component and next molding the tubular body component. Alternatively, the tubular body component may be molded first and the annular component may be molded within, adjacent, or about the tubular body component.
Patent CA-2637074-A1 (CA)
Title: Stabilization of paricalcitol using chlorobutyl or chlorinated butyl stoppers
Inventor: SONG JING FENG
IPC: A61K9/00
Filed: 2007-01-18
Abstract: This invention relates to a method of enhancing the stability of paricalcitol solution in a container by using a chlorobutyl or chlorinated butyl stopper in the container.
Patent CA-2640125-A1 (CA)
Inventor: PARRIS MICHAEL D
IPC: C09K8/72
Filed: 2007-01-23
Abstract: Subterranean formation treatment methods incorporating a rheology model which enables prediction of fluid rheology properties during a treatment operation, where the foundation of the model is a description of the reaction chemistry which describes how the number of crosslinks and broken polymer linkages develops in time under the influence of crosslinkers, breakers, and/or thermally induced effects and pressure effects. In one aspect, when used as a tool for simulating the fluid viscosity, the model can help optimizing the fluid design and optional breaker schedule for a hydraulic fracturing treatment.
Patent CA-2640943-A1 (CA)
Inventor: RAMUNDI MICHAEL
IPC: B65D81/38
Filed: 2008-10-10
Abstract: A portable, foldable, soft-sided insulated container has an a lid mounted carrier, or seat, for a substantially rigid container of a thermal storage medium, such as water. The container assembly may be free of any rigid tub, and may thus retain the ability to fold. The carrier is a substantially rigid plate or panel, or array, that mounts to an otherwise soft panel. The panel, or portion of a panel, to which the rigid carrier mounts is a panel that may tend to stay substantially flat (or, if curved, substantially curved as before) when the container assembly is folded. The seat may be mounted to a portion of the lid, such as a flap that may be opened separately from the top panel more generally. The mounting is such that the substantially rigid thermal storage medium container can slide in and out of the seat. The sliding may be sideways sliding, as opposed to insertion substantially normal to the panel. The seat may stand slightly proud of adjacent members of the bag such that the sideways sliding may tend not to be impeded. When not in use the entire assembly can be folded into a collapsed position for storage.
Patent CA-2641734-A1 (CA)
Inventor: CLARK RICHARD F
IPC: A61K31/427
Filed: 2007-02-15
Abstract: The present invention relates to compounds of formula (I), wherein R1 is selected from the group consisting of hydrogen, cycloalkyl, alkyl and haloalkyl; Y is selected from the group consisting of -(CR4aR-4b)m-, -C(O)-, -O-, -N(H)-, -N(alkyl)- and -S-; wherein m is 1, 2 or 3; Ar3 is phenyl or monocyclic heteroaryl; wherein Ar3 is substituted with 1, 2 or 3 or 4 substituents. Ar1 is selected from the group consisting of phenyl and a monocyclic, five or six- membered heteroaryl; Ar2 is a monocyclic five membered heteroaryl, wherein each Ar2 is independently unsubstituted or substituted with 1 or 2 substituents selected from the group consisting of alkyl, alkenyl, halogen, -CN, -NO2, hydroxy, alkoxy, -NH2, -N(H)(alkyl), -N(alkyl)2. -C(O)OH, -C(O)Oalkyl, -C(O)H, -C(O)alkyl, and haloalkyl; Z is selected from the group consisting of -OR9a, -alkylenyl-OR9a, -NR6R99b; and -alkylenyl-NR6R9b; which inhibit acetyl-CoA carboxylase (ACC) and are useful for the prevention or treatment of metabolic syndrome, type U diabetes, obesity, atherosclerosis and cardiovascular diseases in humans.
Patent CA-2642201-A1 (CA)
Inventor: ORNATSKY OLGA
IPC: G01N33/58
Filed: 2007-02-13
Abstract: Assay methods and kits for kinase and phosphatase enzymes involved in post-translational modifications of proteins are provided. The methods employ elemental analysis, including inductively coupled plasma mass spectrometry (ICP-MS), in conjunction with metal ion coordination complexes such as titanium dioxide or element-tagged antibodies, both of which may have affinity for phosphate groups. The methods allow for convenient and accurate assays for enzymes involved in post-translational modifications of substrates.
Patent CA-2646847-A1 (CA)
Inventor: REMPEL GARRY
IPC: C08C19/02
Filed: 2008-12-16
Abstract: The present invention relates to a process for the hydrogenation of the carbon-carbon double bonds in a diene-based polymer latex in the absence of any organic solvent by a catalytically active system prepared in-situ based on a first main catalyst component and a secondary water-insoluble catalyst component.
Patent CA-2647806-A1 (CA)
Title: Method for preparing differentiated avian cells and genes involved in maintaining pluripotency
Inventor: LAVIAL FABRICE
IPC: C07K14/465
Filed: 2007-03-19
Abstract: Process for preparing differentiated avian cells from avian stem cells grown in a suitable culture medium, comprises induction of stem cell differentiation by inhibiting expression or activity of a gene expressed in the stem cells such as gene 1P06, Nanog and Eomes. Independent claims are included for: (1) a differentiated avian cells obtained by the process; (2) a process for preparing an antiviral vaccine, comprising contacting a virus with avian stem cells having undergone the process; (3) a nucleic acid molecule encoding an interferent RNA; (4) an expression vector comprising a nucleic acid molecule placed under the control of a promoter for the expression of the interferent RNA in a host cell; and (5) an avian stem cells transformed with an expression vector.
Patent CA-2648918-A1 (CA)
Title: Method and means for heating and controlling the temperatures in a sauna
Inventor: HALL KEITH A
IPC: H05B1/02
Filed: 2006-04-10
Abstract: A control panel used in combination with a power unit to control the operation of a sauna. The control panel is equipped with a microprocessor that has software and proper circuitry to allow a user to use buttons to input information into the control panel regarding the time, temperature, and day on which heating within the sauna is to occur. Additionally, the power unit has a microprocessor with a pulse width modulation output that causes individual heating elements to continuously produce varying intensities of heat in order to maintain a consistent desired temperature, and/or intermittently radiate heat creating a wave of heat to be emitted by each individual heating element.